|
|
 |
|
Total Number of Holdings (excluding cash): 49
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
733 |
$64,943.80 |
3.41% |
| Align Technology, Inc. |
ALGN |
016255101 |
330 |
$56,717.10 |
2.97% |
| Penumbra, Inc. |
PEN |
70975L107 |
159 |
$52,449.33 |
2.75% |
| Hoya Corporation |
7741.JP |
J22848105 |
294 |
$51,476.23 |
2.70% |
| Masimo Corporation |
MASI |
574795100 |
287 |
$51,226.63 |
2.69% |
| Waters Corporation |
WAT |
941848103 |
155 |
$47,133.95 |
2.47% |
| Hologic, Inc. |
HOLX |
436440101 |
612 |
$46,518.12 |
2.44% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
2,885 |
$45,980.05 |
2.41% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
561 |
$45,547.59 |
2.39% |
| Alcon Inc. |
ALC.SW |
H01301128 |
574 |
$43,379.91 |
2.28% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
96 |
$43,447.68 |
2.28% |
| The Cooper Companies, Inc. |
COO |
216648501 |
606 |
$42,595.74 |
2.23% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
1,992 |
$41,776.73 |
2.19% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
33 |
$41,798.79 |
2.19% |
| Revvity, Inc. |
RVTY |
714046109 |
470 |
$41,510.40 |
2.18% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
584 |
$41,113.60 |
2.16% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
1,510 |
$41,101.47 |
2.16% |
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
158 |
$40,582.30 |
2.13% |
| DexCom, Inc. |
DXCM |
252131107 |
637 |
$40,264.77 |
2.11% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
383 |
$40,049.08 |
2.10% |
| Teleflex Incorporated |
TFX |
879369106 |
347 |
$39,918.88 |
2.09% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
438 |
$39,858.00 |
2.09% |
| Danaher Corporation |
DHR |
235851102 |
205 |
$39,384.60 |
2.07% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
139 |
$38,760.15 |
2.03% |
| Steris Plc |
STE |
G8473T100 |
176 |
$38,714.72 |
2.03% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
79 |
$38,567.01 |
2.02% |
| Stryker Corporation |
SYK |
863667101 |
114 |
$37,882.20 |
1.99% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
2,352 |
$37,588.04 |
1.97% |
| Medtronic Plc |
MDT |
G5960L103 |
434 |
$37,445.52 |
1.96% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
191 |
$37,283.24 |
1.96% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
525 |
$35,600.25 |
1.87% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,174 |
$35,472.72 |
1.86% |
| Terumo Corporation |
4543.JP |
J83173104 |
2,560 |
$35,035.87 |
1.84% |
| Agilent Technologies, Inc. |
A |
00846U101 |
303 |
$34,796.52 |
1.83% |
| Becton, Dickinson and Company |
BDX |
075887109 |
222 |
$34,481.04 |
1.81% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
153 |
$34,456.86 |
1.81% |
| ResMed Inc. |
RMD |
761152107 |
152 |
$34,189.36 |
1.79% |
| BioMerieux |
BIM.FP |
F1149Y232 |
312 |
$33,728.67 |
1.77% |
| Olympus Corporation |
7733.JP |
J61240107 |
3,440 |
$33,594.35 |
1.76% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
473 |
$32,353.87 |
1.70% |
| Abbott Laboratories |
ABT |
002824100 |
313 |
$32,019.90 |
1.68% |
| Baxter International Inc. |
BAX |
071813109 |
1,889 |
$31,451.85 |
1.65% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
758 |
$31,491.09 |
1.65% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
3,334 |
$29,510.97 |
1.55% |
| Boston Scientific Corporation |
BSX |
101137107 |
434 |
$27,164.06 |
1.42% |
| Insulet Corporation |
PODD |
45784P101 |
132 |
$26,862.00 |
1.41% |
| Cochlear Limited |
COH.AU |
Q25953102 |
223 |
$26,597.82 |
1.40% |
| Amplifon SpA |
AMP.IM |
T0388E118 |
2,423 |
$25,564.45 |
1.34% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
837 |
$24,000.15 |
1.26% |
| US Dollar |
$USD |
|
2,835 |
$2,835.25 |
0.15% |
| Australian Dollar |
$AUD |
|
441 |
$305.44 |
0.02% |
| Euro |
$EUR |
|
13 |
$15.27 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|